Andra språk Novo Nordisk A/S

Aktier

NOVO B

DK0062498333

Farmaceutiska produkter

Marknaden stängd - Nasdaq Copenhagen Andra börsplatser 17.20.00 2026-07-17			5-dagars förändring	Förändring 1 jan.
329,90 ^DKK	−1,76 %		+2,37 %	+1,43 %

18.19	Novo Nordisk lanserar billigare Ozempic-kopia i Sydafrika	RE
17.51	Blandad utveckling på de europeiska börserna – ASML ger personalen engångsbonus	MT

Andra språk

18.19	Novo Nordisk to launch lower-cost Ozempic copy in South Africa
17.51	European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus
15.33	Novo Nordisk's Wegovy Gets Indian Regulator Nod to Treat Aggressive Fatty Liver Disease
15.28	Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator
11.38	US companies face rise in cyber attacks
11.36	US companies face rise in cyber attacks
10.36	India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease
07.32	MORNING BRIEFING - Deutschland/Europa
07-16	Uneinheitlich - Novo Nordisk erhält EU-Zulassung für Wegovy in Pillenform
07-16	European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
07-16	Börsen bauen Verluste aus - Telenor-Zahlen enttäuschen
07-16	Etwas leichter - Technologie-Werte rutschen weiter ab
07-16	MORNING BRIEFING - Deutschland/Europa
07-16	United Laboratories Unit Receives $13.5 Million Milestone Payment From Novo Nordisk
07-16	Novo Nordisk Gets Regulatory Nod to Market Weight Loss Pill in EU
07-15	Novo Nordisk Receives European Commission Approval of Wegovy® Pill as First Oral Glp-1 for Weight Management in the Eu; Single, Ready-To-Use Pen for Higher Dose 7.2 Mg Also Approved
07-15	Novo Nordisk Gets EU Approval for Wegovy Pill for Weight Management
07-15	Novo Nordisk erhält EU-Zulassung für Abnehmpille Wegovy
07-15	Chip-Machine Supplier ASML Raises Guidance Again on Unrelenting AI Demand -- 5th Update
07-15	Novo Nordisk wins EU approval for Wegovy weight-loss pill
07-15	Novo Nordisk's Wegovy Pill Gains EU Approval
07-15	Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
07-15	European Equities Traded in the US as American Depositary Receipts Advance Wednesday
07-15	India's Sun Pharma wins South Africa approval to launch generic Ozempic
07-15	Fake Weight-Loss Medications And New Enforcement Possibilities